We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Cytek Biosciences
CTKB
$576M
| $185K | ﹤0.01% |
12,587
-240
| -2% | -$3.12K |
|
1427
Sally Beauty Holdings
SBH
$1.4B
| $185K | ﹤0.01% |
14,721
-381
| -3% | -$5.29K |
|
1428
Digital Turbine
APPS
$1.02B
| $184K | ﹤0.01% |
12,802
-3,376
| -21% | -$64.5K |
|
1429
TTM Technologies
TTMI
$13.6B
| $184K | ﹤0.01% |
13,955
-328
| -2% | -$4.73K |
|
1430
Cinemark Holdings
CNK
$3.82B
| $181K | ﹤0.01% |
14,935
-384
| -3% | -$6.01K |
|
1431
Upwork
UPWK
$1.09B
| $180K | ﹤0.01% |
13,218
-618
| -4% | -$11.6K |
|
1432
RLJ Lodging Trust
RLJ
$1.87B
| $179K | ﹤0.01% |
17,684
-790
| -4% | -$9.47K |
|
1433
Gossamer Bio
GOSS
$66.5M
| $178K | ﹤0.01% |
14,846
+1,766
| +14% | +$21.9K |
|
1434
Harmonic Inc
HLIT
$1.21B
| $177K | ﹤0.01% |
13,575
-373
| -3% | -$4.03K |
|
|
OPLN
1435
Openlane
OPLN
$4.17B
| $176K | ﹤0.01% |
15,824
-1,208
| -7% | -$18.1K |
|
1436
Mueller Water Products
MWA
$3.92B
| $176K | ﹤0.01% |
17,192
-328
| -2% | -$3.82K |
|
1437
Comstock Resources
CRK
$3.97B
| $174K | ﹤0.01% |
10,107
-193
| -2% | -$3.19K |
|
1438
Adaptive Biotechnologies
ADPT
$3.56B
| $173K | ﹤0.01% |
24,310
+709
| +3% | +$6.68K |
|
1439
Kura Oncology
KURA
$922M
| $173K | ﹤0.01% |
12,621
+303
| +2% | +$4.67K |
|
|
BRSL
1440
Brightstar Lottery PLC
BRSL
$1.91B
| $171K | ﹤0.01% |
10,830
-365
| -3% | -$6.83K |
|
|
VGR
1441
DELISTED
Vector Group Ltd.
VGR
| $171K | ﹤0.01% |
19,433
-497
| -2% | -$5.04K |
|
|
DVAX
1442
DELISTED
Dynavax Technologies
DVAX
| $170K | ﹤0.01% |
16,249
-415
| -2% | -$5.41K |
|
|
CPRX
1443
DELISTED
Catalyst Pharmaceutical
CPRX
| $169K | ﹤0.01% |
13,247
+2,484
| +23% | +$29.4K |
|
1444
Innoviva
INVA
$1.58B
| $169K | ﹤0.01% |
14,549
+216
| +2% | +$2.96K |
|
1445
Liberty Global Class C
LBTYK
$3.27B
| $169K | ﹤0.01% |
10,213
-2,660
| -21% | -$56.4K |
|
1446
Antero Midstream
AM
$10.8B
| $168K | ﹤0.01% |
18,301
+424
| +2% | +$4.18K |
|
1447
Element Solutions
ESI
$9.12B
| $168K | ﹤0.01% |
10,316
-402
| -4% | -$7.5K |
|
1448
Geron
GERN
$911M
| $167K | ﹤0.01% |
71,385
+1,630
| +2% | +$3.65K |
|
1449
Rocket Pharmaceuticals
RCKT
$348M
| $167K | ﹤0.01% |
10,381
+338
| +3% | +$5.27K |
|
1450
First Commonwealth Financial
FCF
$2.12B
| $165K | ﹤0.01% |
12,839
-357
| -3% | -$5K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.